Alexandra Sailer

Alexandra Sailer started their work experience as a Postdoctoral Researcher at HelmholtzZentrum München in February 2016, where they focused on investigating the role of extracellular vesicles in diabetes and obesity. Alexandra also collaborated with industry partners to discover new targets for diabetes treatment. In May 2020, they joined Nuvisan Pharma Services as a Lab Head.

Alexandra Sailer has an extensive education history in the field of Molecular Microbiology. Alexandra began their academic journey in 2005 at Karl-Franzens-Universität Graz, where they obtained a Bachelor of Science degree in Molecular Biology in 2008. Subsequently, Alexandra pursued a Master of Science degree at the same institution from 2008 to 2011, focusing on Molecular Microbiology. During this time, they also had a study abroad experience at Heidelberg University in 2009-2010, although specific details of their degree or field of study there are unavailable.

Continuing their academic pursuits, Alexandra enrolled in a doctoral program at Karl-Franzens-Universität Graz in 2012. Alexandra successfully completed their Doctor of Philosophy (PhD) degree in Molecular Microbiology in 2016. After attaining their PhD, Alexandra potentially pursued further studies at Medizinische Universität Graz from 2011 to 2015. However, there is no information available regarding the specific degree or field of study at this institution.

In summary, Alexandra Sailer has progressively advanced their education with a Bachelor's, Master's, and PhD degrees in Molecular Microbiology. Alexandra'sacademic journey involved attending multiple prestigious universities, including Karl-Franzens-Universität Graz and potentially Medizinische Universität Graz and Heidelberg University, where they focused on various aspects of Molecular Microbiology.